The Economist @TheEconomist
A vaccine is available, but supplies have failed to meet the overwhelming demand. The Food and Drug Administration took nearly two months to approve 1.1m doses from a facility in Denmark https://t.co/qrQvnVnq7r — PolitiTweet.org